financetom
Business
financetom
/
Business
/
Short seller Andrew Left's fraud trial moved to September 2025
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Short seller Andrew Left's fraud trial moved to September 2025
Sep 6, 2024 1:06 PM

NEW YORK, Sept 5 (Reuters) - Prominent activist short

seller Andrew Left will face trial in September 2025 over

allegations he committed fraud, after his lawyers and U.S.

prosecutors agreed to push back the case.

Federal judge in Los Angeles Terry Hatter set Left's trial

for Sept. 30, 2025, in a court document filed on Wednesday. The

trial was originally slated for later this month.

The Justice Department and U.S. Securities and Exchange

Commission in July accused Left of manipulating the market and

defrauding investors with misleading claims about his positions

in multiple stocks, including Nvidia ( NVDA ) and Tesla

.

Left, who has pleaded not guilty, has for more than a decade

been among the most prominent of a cohort of "short activists"

who say they bet against public companies on the basis they are

over-valued or engaging in outright fraud.

The federal authorities said Left used his social media

platform and cable news appearances to promote what he said were

his long or short trades, only to quickly reverse his positions,

making as much as $20 million in the process.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Nio Launches 1st Car Under Onvo Brand, Deliveries Set for September
Market Chatter: Nio Launches 1st Car Under Onvo Brand, Deliveries Set for September
May 15, 2024
01:52 PM EDT, 05/15/2024 (MT Newswires) -- Nio (NIO) launched L60 SUV, its first car under the new brand Onvo, with deliveries set for September, CNBC reported Wednesday. Presales for L60 SUV, which the company says will be about $4,000 cheaper than Tesla's (TSLA) comparable Model Y, started after the launch event, according to the report. Onvo will eventually start...
Virpax Prices Public Offering of Shares, Warrants; Shares Tumble
Virpax Prices Public Offering of Shares, Warrants; Shares Tumble
May 15, 2024
01:55 PM EDT, 05/15/2024 (MT Newswires) -- Virpax Pharmaceuticals ( VRPX ) shares tumbled more than 65% in recent Wednesday trading after the company priced its public offering of slightly more than 1.6 million common shares and related warrants at $1.35 each for gross proceeds of nearly $2.3 million. The five-year series A-1 and 18-month series A-2 warrants to buy...
Forge Resources Reports Soil Studies, Pilot Drilling at Fully-Permitted Coal Project
Forge Resources Reports Soil Studies, Pilot Drilling at Fully-Permitted Coal Project
May 15, 2024
01:50 PM EDT, 05/15/2024 (MT Newswires) -- Forge Resources ( FRGGF ) said Wednesday it initiated comprehensive soil studies and pilot drilling at La Estrella, a fully-permitted coal project in Santander, Colombia. The main objective is to characterize the area and determine the stratigraphic profile of the subsoil, the company said. Key aspects include a technical report detailing soil study...
Takeda Pharmaceutical's Dengue Vaccine Granted WHO Prequalification
Takeda Pharmaceutical's Dengue Vaccine Granted WHO Prequalification
May 15, 2024
01:52 PM EDT, 05/15/2024 (MT Newswires) -- Takeda Pharmaceutical's ( TAK ) dengue vaccine TAK-003 received prequalification from the World Health Organization on Friday, the WHO said Wednesday. TAK-003, a vaccine containing weakened forms of four dengue virus strains, is recommended by the WHO for children aged 6 to 16 years in high-risk areas, administered in two doses with a...
Copyright 2023-2026 - www.financetom.com All Rights Reserved